Grants and Contributions:
Title:
Computational tools for lead optimization in drug design
Agreement Number:
1029248
Agreement Value:
$250,000.00
Agreement Date:
Apr 7, 2025 - Mar 27, 2026
Description:
The project will involve building and improving breadth, efficiency, and accuracy of computational tools for lead optimization in drug design, such as via integration of modern user-interface design, advanced modeling, and artificial intelligence approaches.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Montreal, Quebec, CA H3A 2L1
Reference Number:
172-2025-2026-Q1-1029248
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
802555862
Recipient Type:
For-profit organization
Recipient's Legal Name:
MOLECULAR FORECASTER INC.
Federal Riding Name:
Ville-Marie--Le Sud-Ouest--Île-des-Soeurs
Federal Riding Number:
24077
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710